Clinical Trial Update: Use of a Novel Synbiotic to Change Human Gut Bacteria and Improve Health in Obese Adults [NA]

View source ↗

Summary

A completed clinical trial evaluated a novel synbiotic aimed at modifying gut bacteria to improve health in obese adults; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Microbiota-related Barrier Function Disruption
• Obesity

Snippet

Sponsor: Rush University Medical Center | Conditions: Intestinal Microbiota and Barrier Function | NA | Status: COMPLETED | Results posted: 2021-11-23